Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche expects to keep Rituxan monopoly until 2015
Fierce Pharma
Friday, September 7, 2012 - 12:22pm
tags:
Roche, cancer, Rituxan, biosimilars
3rd Circuit pay-for-delay ruling sparks Nexium antitrust suits
Reuters
Friday, September 7, 2012 - 12:16pm
tags:
Nexium, pay-for-delay, AstraZeneca, Merck
Celgene Arthritis Treatment Meets Primary Goals in Study
NASDAQ.com
Friday, September 7, 2012 - 12:14pm
tags:
Celgene, apremilast, psoriatic arthritis
AstraZeneca evaluating Starpharma cancer drugs
LifeScientist.au
Friday, September 7, 2012 - 12:13pm
tags:
cancer, AstraZeneca, Starpharma
KV Pharma Loses Lawsuit Against FDA Over Makena
Pharmalot
Friday, September 7, 2012 - 12:07pm
tags:
KV Pharmaceutical, FDA, Makena, premature birth
Dr. Reddy's Laboratories Increases Sales but Misses Estimates on Earnings
Motley Fool
Friday, September 7, 2012 - 12:06pm
tags:
earnings, Dr Reddy's
Pharmacyclics Management Discusses Q4 2012 Results - Earnings Call Transcript
Seeking Alpha
Friday, September 7, 2012 - 12:04pm
tags:
earnings, Pharmacyclics
Elan Takes Another Swing
Motley Fool
Friday, September 7, 2012 - 12:04pm
tags:
Elan, ELND005, bipolar disorder
Why Is Carl Icahn Buying Large Blocks Of Forest Laboratories?
Seeking Alpha
Friday, September 7, 2012 - 12:03pm
tags:
Forest Labs, Carl Icahn
Shire settles 1 Intuniv patent infringement lawsuit; Anchen can market generic in July 2016
Yahoo/AP
Friday, September 7, 2012 - 12:02pm
tags:
Shire, Intuniv, patents, Anchen, TWi Pharmaceuticals
Sanofi Reaches New 52-Week High
TheStreet.com
Friday, September 7, 2012 - 11:33am
tags:
Sanofi
Mylan will launch generic Detrol LA in 2014
Yahoo/AP
Friday, September 7, 2012 - 11:33am
tags:
Detrol LA, generics, Mylan, Pfizer, overactive bladder
Another Weight Loss Drug Gets Props from Wall Street
Wall St. Cheat Sheet
Friday, September 7, 2012 - 9:01am
tags:
Contrave, obesity, Orexigen
Is Tofacitinib One Of Pfizer's New Cash Cows?
Seeking Alpha
Friday, September 7, 2012 - 9:00am
tags:
Pfizer, tofacitinib, JNJ, Abbott Labs, rheumatoid arthritis
Bayer, J&J answer FDA query over wider Xarelto use
Reuters
Friday, September 7, 2012 - 8:59am
tags:
Xarelto, FDA, Bayer, JNJ, bloodthinners
Roche ramps up Alzheimer's drug trial as rivals stumble
Yahoo/Reuters
Friday, September 7, 2012 - 8:58am
tags:
Roche, Alzheimer's disease, gantenerumab
Mylan Waits Patiently at the Bottom of the Patent Cliff
Motley Fool
Thursday, September 6, 2012 - 4:23pm
tags:
patents, patent cliff, Mylan, Pfizer, Lipitor, Merck, Singulair, Plavix, Bristol-Myers Squibb
Pfizer Plays Both Sides of the Fence With Mylan
Motley Fool
Thursday, September 6, 2012 - 4:23pm
tags:
Pfizer, Mylan, generics, Japan
Roche Hosts An Encouraging Investor Day
Seeking Alpha
Thursday, September 6, 2012 - 4:15pm
tags:
Roche, JNJ, Immunogen, Abbott Labs, Illumina
FDA OKs Cancer Drugs Faster Than Other Meds
Pharmalot
Thursday, September 6, 2012 - 10:29am
tags:
cancer, FDA, approvals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.